Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Biodar Acquires Karma Pharm
March 1, 2004
1 Min Read
Biodar Acquires Karma Pharm
YAVNE, IsraelBiodar Ltd., a subsidiary of Lycored Ltd. andMahkteshim Agan Industries Ltd., acquired the activities of Karma Pharm. Biodarwill continue Karma Pharms research and development activities in drugdelivery products, while the Karma Pharm founders received $2 million and anundisclosed number of Lycored stock shares.
The combination of Karma Pharm activities and technologies, together withBiodars microencapsulation capabilities will create a synergistic effect,which we believe will lead to the creation of a world-class drug deliverycompany, said Morris Zelkha, chief executive officer of Biodar (www.biodar.com).
You May Also Like